Home / Oil and Gas / Vasculitis Global Clinical Trials Review, H1, 2015

Vasculitis Global Clinical Trials Review, H1, 2015

Published: Apr 2015 | No Of Pages: 81 | Published By: GlobalData

Vasculitis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Vasculitis Global Clinical Trials Review, H1, 2015" provides data on the Vasculitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vasculitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vasculitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Vasculitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Vasculitis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Vasculitis to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Vasculitis 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Vasculitis Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Vasculitis 34
Apr 21, 2015: Kineta, University of Groningen Present New, Positive Data for Dalazatide in ANCA Vasculitis, an Orphan Disease 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Zenyaku Kogyo Co., Ltd. 38
Clinical Trial Overview of Zenyaku Kogyo Co., Ltd. 38
Pluristem Therapeutics Inc. 39
Clinical Trial Overview of Pluristem Therapeutics Inc. 39
GlaxoSmithKline plc 40
Clinical Trial Overview of GlaxoSmithKline plc 40
ChemoCentryx, Inc. 41
Clinical Trial Overview of ChemoCentryx, Inc. 41
AnGes MG, Inc. 42
Clinical Trial Overview of AnGes MG, Inc. 42
Actelion Ltd 43
Clinical Trial Overview of Actelion Ltd 43
AbbVie Inc. 44
Clinical Trial Overview of AbbVie Inc. 44
Clinical Trial Overview of Top Institutes / Government 45
Assistance Publique - Hopitaux de Paris 45
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 45
The National Institute of Allergy and Infectious Diseases 46
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 46
Cambridge University Hospitals NHS Foundation Trust 47
Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 47
Saitama Medical University 48
Clinical Trial Overview of Saitama Medical University 48
Ministry of Health, Labour and Welfare, Japan 49
Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan 49
Nanjing University 50
Clinical Trial Overview of Nanjing University 50
Osaka University 51
Clinical Trial Overview of Osaka University 51
Pitie-Salpetriere Hospital 52
Clinical Trial Overview of Pitie-Salpetriere Hospital 52
University Hospital, Toulouse 53
Clinical Trial Overview of University Hospital, Toulouse 53
University Medical Center Groningen 54
Clinical Trial Overview of University Medical Center Groningen 54
Five Key Clinical Profiles 55
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81

List of Tables
Vasculitis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Vasculitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Vasculitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vasculitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Vasculitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Vasculitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Vasculitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Vasculitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Vasculitis to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15
Vasculitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Vasculitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Vasculitis to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18
Vasculitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Vasculitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Vasculitis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Vasculitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Vasculitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Vasculitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Vasculitis Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Vasculitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Vasculitis Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Vasculitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Vasculitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Vasculitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Vasculitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Vasculitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 35
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 37
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zenyaku Kogyo Co., Ltd., 2015* 38
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2015* 39
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 40
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by ChemoCentryx, Inc., 2015* 41
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2015* 42
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2015* 43
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 44
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 45
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 46
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2015* 47
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2015* 48
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2015* 49
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing University, 2015* 50
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2015* 51
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pitie-Salpetriere Hospital, 2015* 52
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2015* 53
Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2015* 54

List of Figures
Vasculitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Vasculitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Vasculitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vasculitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Vasculitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Vasculitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Vasculitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Vasculitis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Vasculitis to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15
Vasculitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Vasculitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Vasculitis to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18
Vasculitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Vasculitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Vasculitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Vasculitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Vasculitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Vasculitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Vasculitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Vasculitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Vasculitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Vasculitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Vasculitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 80

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +